Monday, December 12, 2022
JOIN THE CONVERSATION
The pharmaceutical industry requires effective tactics to address the problem of developing drugs to reach intracellular drug targets. Conventional methods to visualize pharmacokinetics inside the cell too often prove unsatisfactory. In particular, when attempting to accurately determine drug exposure, traditional plasma concentration measurements fall short.
Recently, a research incubator group embedded within AstraZeneca’s BioVentureHub tried a new approach. The scientists applied NanoSIMS advanced imaging functionalities within a specialized workflow, creating a proven new solution for quantifying subcellular drug concentrations: DrugSIMS™.
Download our white paper Introducing DrugSIMS: a new approach unveils drug targets inside the “black box” of the cell to learn more!
DOWNLOAD NOW